Biosystems International
About:
Biosystems International is a biotechnology company engaged in the development of blood-based diagnostics for cancer and chronic diseases.
Website: http://www.biosys-intl.com
Top Investors: Amundi Private Equity Funds, Societe Generale Asset Management
Description:
BioSystems International (BSI) brings biomarkers to the bedside. They improve pharmaceutical drug discovery and development productivity, i.e. safer and more effective drugs at lower costs and in less time. BSI delivers tools for disease management.
Total Funding Amount:
$13.9M
Headquarters Location:
Debrecen, Debrecen, Hungary
Founded Date:
2004-01-01
Contact Email:
info(AT)biosys-intl.com
Founders:
András GUTTMAN, Laszlo Takacs
Number of Employees:
11-50
Last Funding Date:
2020-10-29
IPO Status:
Private
Industries:
© 2025 bioDAO.ai